生存率-话题@MedSci

#生存率#

482篇内容 | 3119人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1256685, encodeId=4948125668570, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Anesthesiology：丙泊酚静脉麻醉的结肠癌手术患者术后生存率高于地氟醚麻醉者, objectType=article, longId=154759, objectId=4a01154e5919, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a01154e5919, replyNumber=0, likeNumber=0, createdTime=2018-12-01, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a01154e5919, moduleTitle=Anesthesiology：丙泊酚静脉麻醉的结肠癌手术患者术后生存率高于地氟醚麻醉者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a01154e5919)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256684, encodeId=fd991256684fa, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=DDS： Barrett食管的早期诊断能改善食管腺癌的生存率, objectType=article, longId=153962, objectId=77e215396219, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77e215396219, replyNumber=0, likeNumber=56, createdTime=2018-11-21, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77e215396219, moduleTitle=DDS： Barrett食管的早期诊断能改善食管腺癌的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77e215396219)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256683, encodeId=8bae12566837a, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=MYSTIC研究：durvalumab与tremelimumab联用无法显著提高肺癌患者的生存率, objectType=article, longId=153840, objectId=5663153840a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5663153840a9, replyNumber=0, likeNumber=71, createdTime=2018-11-20, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5663153840a9, moduleTitle=MYSTIC研究：durvalumab与tremelimumab联用无法显著提高肺癌患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5663153840a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256682, encodeId=4edd1256682b8, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Ann Rheum Dis：系统性硬化症患者间质性肺病的短期进展预测长期生存率, objectType=article, longId=153504, objectId=58ed15350477, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58ed15350477, replyNumber=0, likeNumber=80, createdTime=2018-11-16, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58ed15350477, moduleTitle=Ann Rheum Dis：系统性硬化症患者间质性肺病的短期进展预测长期生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58ed15350477)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256681, encodeId=ddf4125668145, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JACC：缺血性心脏病危险因素的控制与生存率, objectType=article, longId=152446, objectId=a5ea15244607, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a5ea15244607, replyNumber=0, likeNumber=54, createdTime=2018-11-02, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a5ea15244607, moduleTitle=JACC：缺血性心脏病危险因素的控制与生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a5ea15244607)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256680, encodeId=7a92125668009, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=DCR：化放疗后巩固mFOLFOX6化疗可改善晚期直肠癌患者的生存率, objectType=article, longId=150473, objectId=28f61504e3f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28f61504e3f0, replyNumber=0, likeNumber=75, createdTime=2018-10-08, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28f61504e3f0, moduleTitle=DCR：化放疗后巩固mFOLFOX6化疗可改善晚期直肠癌患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28f61504e3f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256679, encodeId=208e12566e902, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=J Gastroenterology：PT-INR恢复至小于1.3可提高严重急性肝损伤患者的生存率, objectType=article, longId=150364, objectId=b80e150364f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b80e150364f7, replyNumber=0, likeNumber=74, createdTime=2018-10-06, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b80e150364f7, moduleTitle=J Gastroenterology：PT-INR恢复至小于1.3可提高严重急性肝损伤患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b80e150364f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256678, encodeId=c78d12566e8ec, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=为什么我国甲状腺癌患者5年生存率与美国差距较大？, objectType=article, longId=149946, objectId=ee6e1499461f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee6e1499461f, replyNumber=0, likeNumber=60, createdTime=2018-09-30, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee6e1499461f, moduleTitle=为什么我国甲状腺癌患者5年生存率与美国差距较大？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee6e1499461f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256677, encodeId=dbae12566e7b5, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=BMC Gastroenterology：托伐普坦可改善腹水和低钠血症的肝硬化患者的生存率, objectType=article, longId=148988, objectId=b9141489889b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9141489889b, replyNumber=0, likeNumber=74, createdTime=2018-09-18, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9141489889b, moduleTitle=BMC Gastroenterology：托伐普坦可改善腹水和低钠血症的肝硬化患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b9141489889b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256676, encodeId=475612566e6b2, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=肺癌诊治有了“上海标准”，多项研究成果提升患者生存率, objectType=article, longId=148824, objectId=7a5c14882431, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a5c14882431, replyNumber=0, likeNumber=60, createdTime=2018-09-15, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a5c14882431, moduleTitle=肺癌诊治有了“上海标准”，多项研究成果提升患者生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a5c14882431)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256675, encodeId=44e812566e5cf, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Heart：接受外科冠脉手术的先心病患者远期生存率尚可, objectType=article, longId=147799, objectId=5ee214e79926, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ee214e79926, replyNumber=0, likeNumber=85, createdTime=2018-09-01, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ee214e79926, moduleTitle=Heart：接受外科冠脉手术的先心病患者远期生存率尚可, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ee214e79926)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256674, encodeId=d2bf12566e430, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Gastroenterology：诺氟沙星可提高低腹水蛋白浓度肝硬化患者的生存率, objectType=article, longId=147585, objectId=5f6314e585d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f6314e585d4, replyNumber=0, likeNumber=60, createdTime=2018-08-30, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f6314e585d4, moduleTitle=Gastroenterology：诺氟沙星可提高低腹水蛋白浓度肝硬化患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f6314e585d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256673, encodeId=5cb112566e3a4, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JAMA：测那么多基因也没用？耶鲁科学家发现，广谱基因检测不能提高晚期非小细胞肺癌患者生存率, objectType=article, longId=147295, objectId=37f514e29567, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37f514e29567, replyNumber=0, likeNumber=75, createdTime=2018-08-25, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37f514e29567, moduleTitle=JAMA：测那么多基因也没用？耶鲁科学家发现，广谱基因检测不能提高晚期非小细胞肺癌患者生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=37f514e29567)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256672, encodeId=d37812566e232, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Heart：作为移植过渡的左心室辅助装置患者的生存率及治疗预后, objectType=article, longId=147178, objectId=8d5714e17892, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d5714e17892, replyNumber=0, likeNumber=74, createdTime=2018-08-23, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d5714e17892, moduleTitle=Heart：作为移植过渡的左心室辅助装置患者的生存率及治疗预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d5714e17892)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256671, encodeId=d91512566e11d, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Lancet：1型糖尿病：发病年龄影响生存率和心血管结局？, objectType=article, longId=146532, objectId=52ec1465321e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52ec1465321e, replyNumber=0, likeNumber=55, createdTime=2018-08-14, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52ec1465321e, moduleTitle=Lancet：1型糖尿病：发病年龄影响生存率和心血管结局？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52ec1465321e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256670, encodeId=bb9e12566e08a, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=J Rheumatol：系统性硬化症—系统性红斑狼疮重叠综合征的流行病学和生存率, objectType=article, longId=146423, objectId=5f881464231d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f881464231d, replyNumber=0, likeNumber=92, createdTime=2018-08-13, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f881464231d, moduleTitle=J Rheumatol：系统性硬化症—系统性红斑狼疮重叠综合征的流行病学和生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f881464231d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256669, encodeId=50b4125666956, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=J Hepatol：FOLFOX肝动脉灌注可改善晚期肝细胞癌生存率？, objectType=article, longId=146110, objectId=147214611030, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=147214611030, replyNumber=0, likeNumber=66, createdTime=2018-08-09, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=147214611030, moduleTitle=J Hepatol：FOLFOX肝动脉灌注可改善晚期肝细胞癌生存率？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=147214611030)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256668, encodeId=5c1d12566689c, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=CCLM：结直肠腺癌中microRNA-28-5p高表达可预测淋巴结阴性患者的短期复发和非转移性疾病患者较低的总体生存率, objectType=article, longId=145555, objectId=1638145555dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1638145555dc, replyNumber=0, likeNumber=63, createdTime=2018-08-02, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1638145555dc, moduleTitle=CCLM：结直肠腺癌中microRNA-28-5p高表达可预测淋巴结阴性患者的短期复发和非转移性疾病患者较低的总体生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1638145555dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256667, encodeId=fc12125666e9c, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=J Hepatol：直接抗病毒药物提高了肝移植后患者的早期生存率，并引起肝移植等待名单的显著变化, objectType=article, longId=145195, objectId=f7b21451958d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7b21451958d, replyNumber=0, likeNumber=60, createdTime=2018-07-27, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7b21451958d, moduleTitle=J Hepatol：直接抗病毒药物提高了肝移植后患者的早期生存率，并引起肝移植等待名单的显著变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f7b21451958d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256666, encodeId=133f1256666a4, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JAHA：冠状动脉旁路移植术患者的虚弱与长期生存率的关系, objectType=article, longId=144884, objectId=0a6714488456, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a6714488456, replyNumber=0, likeNumber=78, createdTime=2018-07-22, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a6714488456, moduleTitle=JAHA：冠状动脉旁路移植术患者的虚弱与长期生存率的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a6714488456)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

生存率

2020-05-29

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Anesthesiology：丙泊酚静脉麻醉的结肠癌手术患者术后生存率高于地氟醚麻醉者

2018-12-01

guoyibin (审核中...)

前往app查看评论内容

#生存率#

DDS： Barrett食管的早期诊断能改善食管腺癌的生存率

2018-11-21

guoyibin (审核中...)

前往app查看评论内容

#生存率#

MYSTIC研究：durvalumab与tremelimumab联用无法显著提高肺癌患者的生存率

2018-11-20

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Ann Rheum Dis：系统性硬化症患者间质性肺病的短期进展预测长期生存率

2018-11-16

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JACC：缺血性心脏病危险因素的控制与生存率

2018-11-02

guoyibin (审核中...)

前往app查看评论内容

#生存率#

DCR：化放疗后巩固mFOLFOX6化疗可改善晚期直肠癌患者的生存率

2018-10-08

guoyibin (审核中...)

前往app查看评论内容

#生存率#

J Gastroenterology：PT-INR恢复至小于1.3可提高严重急性肝损伤患者的生存率

2018-10-06

guoyibin (审核中...)

前往app查看评论内容

#生存率#

为什么我国甲状腺癌患者5年生存率与美国差距较大？

2018-09-30

guoyibin (审核中...)

前往app查看评论内容

#生存率#

BMC Gastroenterology：托伐普坦可改善腹水和低钠血症的肝硬化患者的生存率

2018-09-18

guoyibin (审核中...)

前往app查看评论内容

#生存率#

肺癌诊治有了“上海标准”，多项研究成果提升患者生存率

2018-09-15

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Heart：接受外科冠脉手术的先心病患者远期生存率尚可

2018-09-01

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Gastroenterology：诺氟沙星可提高低腹水蛋白浓度肝硬化患者的生存率

2018-08-30

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JAMA：测那么多基因也没用？耶鲁科学家发现，广谱基因检测不能提高晚期非小细胞肺癌患者生存率

2018-08-25

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Heart：作为移植过渡的左心室辅助装置患者的生存率及治疗预后

2018-08-23

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Lancet：1型糖尿病：发病年龄影响生存率和心血管结局？

2018-08-14

guoyibin (审核中...)

前往app查看评论内容

#生存率#

J Rheumatol：系统性硬化症—系统性红斑狼疮重叠综合征的流行病学和生存率

2018-08-13

guoyibin (审核中...)

前往app查看评论内容

#生存率#

J Hepatol：FOLFOX肝动脉灌注可改善晚期肝细胞癌生存率？

2018-08-09

guoyibin (审核中...)

前往app查看评论内容

#生存率#

CCLM：结直肠腺癌中microRNA-28-5p高表达可预测淋巴结阴性患者的短期复发和非转移性疾病患者较低的总体生存率

2018-08-02

guoyibin (审核中...)

前往app查看评论内容

#生存率#

J Hepatol：直接抗病毒药物提高了肝移植后患者的早期生存率，并引起肝移植等待名单的显著变化

2018-07-27

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JAHA：冠状动脉旁路移植术患者的虚弱与长期生存率的关系

2018-07-22

科室
- - 订阅+
  - 更多科室
工具
服务